InnovaCore Center for Research and Biotechnology

08/03/2025

When Science Slips: The Hidden Cost of Misleading Data

In the high-stakes world of scientific discovery, I have come to see just how much each dataset shapes the story and how even a single error can echo far beyond the lab. In this editorial, Sohail Rao, MD, MA, DPhil, reflects on the consequences of misleading or manipulated data and how it can quietly distort the scientific narrative, misguide clinical decisions, and erode public trust.

But this isn’t just a reflection; it is a call to action. As researchers, reviewers, editors, and institutions, we share a collective responsibility to uphold the ethical foundations of academic publishing and protect the credibility of our work.

Read the full editorial here:

08/01/2025

Invisible Risks, Unequal Burdens: The HPV Crisis in Rural America

While HPV is the most common sexually transmitted infection in the U.S., its consequences are not distributed equally. Women in rural areas face significantly higher rates of HPV infection, cervical cancer, and mortality.

In their compelling narrative review, Kari Hooper, MD, and Sohail Rao, MD, MA, DPhil, thoroughly examine the structural, cultural, and clinical factors that contribute to these disparities. From limited access to screening and vaccination to cultural stigma and geographic isolation, this article underscores the silent epidemic affecting underserved women across rural America.

Why should you read it? This paper not only highlights the problem but also offers evidence-based, community-centered solutions that can guide public health interventions, academic research, and policy reform.

Read the full article: https://innovapath.us/index.php/IN/article/view/92/58

07/05/2025

Call for Submissions – INNOVAPATH™ Journal of Translational and Clinical Medicine & Biotechnology

Are you conducting groundbreaking research in translational medicine, clinical research, or biotechnology? INNOVAPATH™ invites submissions for original research, reviews, and more! With rigorous peer review, rapid publication, and open access, this is your platform to help shape the future of evidence-based clinical care.

Learn more & submit: www.innovapath.us

Official ISSN: 3067-8102 | Indexed in Google Scholar, SCOPUS & soon Web of Science.

06/13/2025

AI, AGI, and the Evolution of Evidence in Clinical Decision-Making

In this timely article, Dr. Sohail Rao explores how Artificial Intelligence (AI), Artificial General Intelligence (AGI), and emerging technologies are being used to simulate, predict, and optimize clinical interventions. The piece critically examines AI's evolving role in clinical decision support, highlighting the ethical and regulatory boundaries that still require human oversight.

The article calls for a future rooted in hybrid models, where AI enhances efficiency, but human judgment preserves the rigor and reliability that evidence-based medicine demands.

Read the full article here:

06/11/2025

Rethinking Clinical Trials in the Age of AI and AGI

Prospective interventional studies are the foundation of evidence-based medicine. However, this foundation is being questioned due to the rapid rise of Artificial Intelligence (AI) and the conceptual emergence of Artificial General Intelligence (AGI).

This insightful manuscript explores whether AI and AGI can augment or replace traditional clinical trials. It examines AI's current capabilities in trial design, decision support, and retrospective analysis while highlighting the ethical, methodological, and regulatory limits of depending solely on machines. AGI may promise more, but it also poses risks: bias, lack of transparency, and unclear validation pathways.

The future may lie in hybrid trial models, where human science and machine intelligence collaborate without compromising rigor.

Read the full article:

06/05/2025

A Landmark Breakthrough in Transfusion Medicine

Japanese scientists have developed a revolutionary form of artificial blood that is compatible with all blood types...a discovery that could transform how we respond to medical emergencies, trauma care, and disasters.

This innovation addresses one of the most critical challenges in emergency medicine: the availability and matching of blood types during urgent situations. Universal artificial blood could:
- Save lives in trauma and battlefield settings
- Reduce dependence on blood donations
- Improve care in remote or resource-limited areas
- Ensure safer, faster transfusions during mass casualty events

While still in the experimental stage, this advancement represents a major step toward reshaping the future of transfusion medicine.

Read more:

Artificial blood could reduce preventable deaths in settings where limited supply costs millions of lives in low-income countries.

05/29/2025

Bridging the Gap: Empowering Community Hospitals Through National Research Networks

In this insightful article published by Sohail Rao explores a transformative opportunity for community hospitals to join National Clinical Research Networks (NCRNs). Drawing from his own real-world experience, the author highlights how these collaborations can dramatically improve patient care, expand access to clinical trials, and position local and regional hospitals at the forefront of medical innovation.

For healthcare leaders, administrators, and research advocates, this article offers a compelling roadmap to elevate clinical outcomes, foster innovation, and close the divide between frontline care and academic research.

Read the full article here:

05/15/2025

Strengthening Ties in Healthcare Innovation: Dr. Zafar Zaidi Visits INNOVACORE and CorePath

We were honored to host Dr. Zafar Zaidi, CEO of Indus Hospital & Health Network at INNOVACORE Center for Research and Biotechnology and CorePath Laboratories earlier today.

The visit featured engaging and productive discussions focused on forging strategic collaborations in clinical and translational research, academic training programs, and advanced diagnostic technologies. Dr. Zaidi’s visit underscores a shared vision to expand the frontiers of healthcare innovation and scientific advancement in Pakistan and beyond.

We are excited about the potential opportunities that lie ahead and look forward to translating today’s conversations into meaningful partnerships that benefit patients and the broader medical community.

I remain deeply enthusiastic about my humble role as Chief Scientific Officer (Pro Bono) and Chair of the Scientific Research Committee at the Indus Hospital and Health Network...a committee that recently completed the development of a Research Strategic Plan aimed at fostering a robust culture of evidence-based clinical care

05/10/2025

FICT 2025 at DUHS: Advancing Transplantation Through Global Collaboration

Welcome to a special look into the First International Conference on Transplantation (FICT 2025), hosted by Dow University of Health Sciences (DUHS); a landmark event that placed Pakistan at the forefront of global dialogue on organ transplantation.

Held in Karachi, Pakistan, FICT 2025 convened a distinguished gathering of international and national leaders in transplantation medicine, bioethics, and healthcare policy. Over the course of several days, participants engaged in high-impact keynote addresses, panel discussions, and scientific sessions covering cutting-edge research, clinical innovations, and the ethical challenges surrounding organ donation and transplantation.

This conference also marked the beginning of key collaborations uniting academic institutions, clinical networks, and policymakers in the shared goal of advancing transplantation care, improving accessibility, and increasing public awareness, particularly within culturally and religiously sensitive contexts.

Whether you're a healthcare professional, researcher, policymaker, or student, this video offers a glimpse into the energy, vision, and shared commitment that defined FICT 2025. Join us as we reflect on this transformative milestone in DUHS’s journey toward excellence in research, education, and patient care.

FICT 2025 at DUHS: Advancing Transplantation Through Global CollaborationWelcome to a special look into the First International Conference on Transplantation...

05/02/2025

Inspiring the Next Generation of Scientists at UTSA’s Honey Pathway Program

Earlier today, I had the distinct pleasure of attending a student breakfast hosted by the Honey Pathway Program at the University of Texas at San Antonio (UTSA)—a transformative initiative committed to nurturing talent, fostering academic confidence, and expanding representation in STEM fields. This visit was made possible through the kind invitation of Dr. Ferhat Ozturk, Director, Honey Pathway Program whose commitment to student development and mentorship is truly commendable.

As I stood before a room filled with driven, inquisitive, and passionate students—each wearing the Honey Pathway colors with pride—I couldn’t help but feel hopeful about the future of science and healthcare. This program is more than just a pathway; it is a launchpad for diverse and talented students who may not have had traditional access to research experiences or mentorship in the sciences.

During my remarks, I introduced them to several initiatives that may serve as platforms for their growth and global engagement:

INNOVACORE Center for Research & Biotechnology
Our innovation and research engine focused on translating ideas into impactful biomedical solutions, fostering student-led innovation, and creating collaborative opportunities between academic institutions and clinical research.

INNOVAPATH - The Premier Journal Bridging Discovery with Innovation
A peer-reviewed, open-access scientific journal designed specifically to amplify emerging voices in the fields of biomedical sciences, public health, and healthcare innovation. I extended a warm invitation to the students to submit their original work, reviews, or reflections—because their voices matter, and the world needs their perspectives.

HBond Foundation - a 501 (C)3 Nonprofit
A humanitarian initiative rooted in the belief that education and scientific equity are foundational to better healthcare systems. The Foundation supports emerging scholars and provides platforms for service, leadership, and cross-border collaboration.

I was struck not only by the students’ academic curiosity, but by their thoughtful questions and sincere desire to make a difference. These are the future clinicians, researchers, and health equity advocates our world so urgently needs. The event was a reminder that mentorship, opportunity, and belief in young talent can be transformative. The Honey Pathway Program at UTSA is doing precisely that—building bridges to excellence and inclusion in science.

To the students I met that morning...keep exploring. Keep questioning. Keep believing in your capacity to lead. I look forward to reading your future publications in INNOVAPATH and to seeing the impact you will create in the world of science and medicine.

To learn more about INNOVACORE: https://innovacore.net/

To learn more about INNOVAPATH: https://innovapath.us/index.php/IN

To learn more about HBond Foundation: https://hbond.org/

04/03/2025

I am so excited and honored to be on my way from San Antonio to Karachi to participate in the First International Conference on Transplantation at Dow University of Health Sciences Official from April 09-13, 2025. It’s a privilege to be attending this prestigious event at the invitation of Prof. Saeed Quraishy, Vice-Chancellor of DUHS. Looking forward to meaningful discussions and collaborations!

03/29/2025

LEARN FROM WORLD RENOWNED EXPERT IN PATHOLOGY!

Join us at the Pre-Conference Program of the First International Conference on Transplantation (FICT 2025) organized by the Dow University of Health Sciences Official. Gain exclusive insights through hands-on, case-based microscopy sessions and discussions led by Dr. Aamir Ehsan, MD

ABOUT DR. AAMIR EHSAN:

Dr. Aamir Ehsan is American Board Certified in anatomic and clinical pathology, hematopathology, molecular genetics and transfusion medicine. As the CEO of CorePath Laboratories and Former Chief of Pathology at VA Medical Center, Texas, he has also served as a faculty member at UT Health Science Center, San Antonio.

Renowned for his groundbreaking work in hematologic malignancies, lymph node pathology, and digital pathology solutions, Dr. Ehsan brings a wealth of knowledge and experience to FICT 2025. Don't miss his exclusive sessions!

CME: 2 credit hours per session

To learn more, please visit this website:https://www.duhs.edu.pk/wp-content/uploads/2025/03/Handbook-Web-Verion.pdf